Abstract
In our paper “Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection”, we used an enhanced dataset from the National Cancer Database (NCDB) to compare 5-year overall survival (OS) and disease recurrence in propensity matched patients undergoing lobectomy or sublobar resection for clinical stage IA non-small cell lung cancer (NSCLC) (1). We found that 5-year OS was similar between cohorts. However, those undergoing sublobar resection were identified to have a 39% increased risk of cancer recurrence.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
